Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 3 | 3 | 3 | 3 |
| Accounts receivable | -615 | -72 | 199 | 23 | -903 |
| Accounts payable and accrued liabilities | 625 | N/A | N/A | N/A | N/A |
| Other Working Capital | 86 | 435 | 329 | 762 | -865 |
| Other Operating Activity | -231 | -824 | -278 | -1,025 | -260 |
| Operating Cash Flow | $-132 | $-457 | $253 | $-237 | $-2,024 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 1 | 0 | 0 | -30 |
| Investing Cash Flow | $0 | $1 | $0 | $0 | $-30 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400 | 0 | 0 | 150 | 150 |
| Debt Repayment | -43 | -25 | -28 | -20 | -23 |
| Other Financing Activity | -19 | -26 | -18 | -19 | -19 |
| Financing Cash Flow | $338 | $-51 | $-46 | $112 | $108 |
| Exchange Rate Effect | 0 | -1 | 0 | 0 | 1 |
| Beginning Cash Position | 94 | 603 | 396 | 521 | 2,466 |
| End Cash Position | 301 | 94 | 603 | 396 | 521 |
| Net Cash Flow | $206 | $-507 | $207 | $-125 | $-1,946 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132 | -457 | 253 | -237 | -2,024 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -30 |
| Free Cash Flow | -132 | -457 | 253 | -237 | -2,054 |